Produce Prescription Subsidy for Patients With Diabetes A Pragmatic Randomized Clinical Trial

02/16/26 

Importance  Patients with diabetes and food insecurity are at greater risk of adverse health outcomes. Effective strategies to promote healthy food access are urgently needed.

Objective  To evaluate the effect of a produce prescription (PRx) program on cardiometabolic health outcomes and health care utilization among patients with diabetes who were at risk of food insecurity.

Design, Setting, and Participants  This 2-arm, pragmatic, randomized clinical trial was conducted in an integrated academic health system in the southeastern US, and patients were recruited from June to August 2023 and followed up for 12 months. Patients were randomly assigned to be offered a PRx (treatment group) or continued to receive usual care (comparison group). Inclusion criteria included a diabetes diagnosis and being at risk for food insecurity. Randomization was stratified by mean hemoglobin A1c (HbA1c) level during the past year (≥8% vs <8%). Data were analyzed from October 2024 to April 2025….

Read full article at JAMA Internal Medicine 

Facebook
Twitter
LinkedIn
Email

Subscribe to our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*